Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | MRNA | Sale | 15,000 | $134.49 | $2.0M |
| Sep 10, 2026 | MRNA | Sale | 19,836 | $134.49 | $2.7M |
| Nov 29, 2024 | MRNA | Sale | 1,420 | $42.79 | $61K |
| Oct 7, 2024 | MRNA | Sale | 715 | $60.12 | $43K |
| Aug 29, 2024 | MRNA | Sale | 162 | $78.03 | $13K |
| Aug 28, 2024 | MRNA | Sale | 1,321 | $79.39 | $105K |
| Jul 8, 2024 | MRNA | Sale | 689 | $118.24 | $81K |
| Jun 3, 2024 | MRNA | Sale | 691 | $140.72 | $97K |
| May 29, 2024 | MRNA | Sale | 183 | $144.50 | $26K |
| May 28, 2024 | MRNA | Sale | 648 | $162.47 | $105K |
| Apr 8, 2024 | MRNA | Sale | 705 | $101.93 | $72K |
| Feb 29, 2024 | MRNA | Sale | 647 | $94.57 | $61K |
| Jan 8, 2024 | MRNA | Sale | 772 | $109.75 | $85K |
| Oct 6, 2023 | MRNA | Sale | 2,858 | $102.50 | $293K |
| Jun 24, 2022 | RVTY | Sale | 2,072 | $144.90 | $300K |
| Jun 24, 2022 | RVTY | Sale | 663 | $146.34 | $97K |
| Jun 24, 2022 | RVTY | Sale | 2,290 | $145.78 | $334K |
| Sep 20, 2021 | RVTY | Sale | 1,803 | $183.93 | $332K |
| Sep 20, 2021 | RVTY | Sale | 1,377 | $185.30 | $255K |
| Sep 20, 2021 | RVTY | Sale | 400 | $186.09 | $74K |
| Sep 20, 2021 | RVTY | Sale | 100 | $187.99 | $19K |
| Sep 20, 2021 | RVTY | Sale | 1,300 | $183.18 | $238K |
| Sep 20, 2021 | RVTY | Sale | 1,100 | $187.17 | $206K |
| Oct 2, 2020 | RVTY | Sale | 4,423 | $124.58 | $551K |
| Oct 2, 2020 | RVTY | Sale | 1,100 | $123.69 | $136K |
| Oct 2, 2020 | RVTY | Sale | 100 | $125.08 | $13K |
SEC reporting-owner ID (CIK) 1736359 · all filings on EDGAR